Consequently, the inhibition of the NRF2 pathway may exert an epistatic interaction with other driving variants, resulting in the suppression of cancer growth.39The primary objective of our investigation was to examineNFE2L2, given its high frequency of genetic alterations in lung cancer and its established correlation with adverse clinical outcomes. Here, NFE2L2 is linked to lung carcinoma.